Researchers traced a patient's nonadherence to cardiovascular disease (CVD)-related medications to the number of medications an individual is prescribed as well as at what times these medications need to be taken. While prescribed CVD medications control associated risk factors such as hypertension and hyperlipidemia, more than half of the patients on a prescribed medication plan fail to take their prescriptions as needed.
Researchers traced a patient’s nonadherence to cardiovascular disease (CVD)-related medications to the number of medications an individual is prescribed as well as at what times these medications need to be taken. While prescribed CVD medications control associated risk factors such as hypertension and hyperlipidemia, more than half of the patients on a prescribed medication plan fail to take their prescriptions as needed.
According to the report, the study examined patients enrolled in a clinical trial who were receiving care in the Veterans Affairs healthcare system and who were reported to have poorly controlled CVD risk factors. These individuals not only demonstrated an uncontrolled disease status but also provided a “unique perspective on barriers to medication adherence,” say the authors. The study was guided by the Health Decision Model, in which the researchers believed that a patient’s perceptions of barriers would ultimately affect their health decisions.
“Patients who reported medication nonadherence experienced higher medication barrier scores,” the report stated. “Obtaining information about medication barriers from the patient’s perspective is critical in order to know where and how to intervene to improve medication adherence.”
The study discovered that individuals who were not employed or who did not have a strong social support system such as someone to help with tasks when needed, recorded high medication barrier scores. Additionally, when researchers dissected the results from patients facing both hypertension and hyperlipidemia, they discovered that individuals diagnosed with hypertension alone presented higher medication barrier scores.
Highlighting the importance of a social support system, the researchers concluded that family support alone creates a positive correlation with medication adherence with respect to hypertension as a CVD risk factor. The study suggested that available tools for self-monitoring, reminders on smartphone applications, and Web-based software may help reconcile medication nonadherence when it comes to the common barriers such as having too many medications to take at one time or forgetting to take the medications when prescribed.
“Linking patients with existing resources of relevance to their specific barriers is critical to address problems and subsequently improve medication adherence,” the report stated.
To read the full report, click here: http://bit.ly/1KRwYLW
Drug Overdoses Leading to Cardiac Arrest Rising, Particularly With Stimulant-Opioid Combination
November 25th 2023A population-based study found that out-of-hospital cardiac arrest events resulting from drug overdoses have significantly increased from 2015 to 2021, particularly among patients who have taken a combination of stimulants and opioids.
Read More
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
New Study Links Sphingolipids With Palmitic Acid to Increased Risk of Sudden Cardiac Death
November 17th 2023Plasma ceramides and sphingomyelins with palmitic acid were linked to a 34% and 37% increased risk of sudden cardiac death (SCD) per higher SD of log sphingolipid levels, respectively.
Read More
Rates of Elevated LDL-C Have Decreased, but Awareness, Treatment Still Suboptimal
November 6th 2023The prevalence of severely elevated low-density lipoprotein cholesterol (LDL-C) has declined in recent decades, but 1 in 17 US adults in a recent analysis had levels of LDL-C that would warrant consideration of pharmacotherapy, and 1 in 48 had high levels of LDL-C that are indicated for medication.
Read More